Sign in to view content

Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2018

Related

A Novel Biocompatible Film to Promote Retinals Breaks Repair and Macular Hole Closure
Stanislao Rizzo, MD
Annual Meeting Talks
2018
Prospective Evaluation of Pain and Inflammation Following Injection of Aflibercept or Ranibizumab in Patients With Diabetic Macular Edema: SOLAR Study
Nikolas JS London, MD, FACS, FASRS
Annual Meeting Talks
2018
Quantitative Ultra-widefield Angiography: Correlation of Microaneurysm Burden With Anatomic and Angiographic Features in Diabetic Retinopathy
Joseph D Boss, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more